We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in Five Prime Therapeutics, Inc. in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 147 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 147 → 0 (-147)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $1.56B → $0 (-$1.56B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 147

Holders
–
Holders Change
-147
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
147
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
BI
BVF Inc
California
-$239M
2
BlackRock
BlackRock
New York
-$116M
3
RSCM
Rock Springs Capital Management
Maryland
-$100M
4
MF
Magnetar Financial
Illinois
-$90.6M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$81.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
Zurich Cantonal Bank
126
Zurich Cantonal Bank
Switzerland
– -$129K -3,415 Closed
Osaic Holdings
127
Osaic Holdings
Arizona
– -$129K -3,402 Closed
CM
128
Caption Management
Oklahoma
– -$102K -2,700 Closed
AIP
129
Ameritas Investment Partners
Nebraska
– -$100K -2,650 Closed
Legal & General Group
130
Legal & General Group
United Kingdom
– -$100K -2,646 Closed
CG
131
Cutler Group
California
– -$82K -2,200 Closed
PAM
132
Panagora Asset Management
Massachusetts
– -$83K -2,192 Closed
Pacer Advisors
133
Pacer Advisors
Pennsylvania
– -$78K -2,062 Closed
CAPTRUST Financial Advisors
134
CAPTRUST Financial Advisors
North Carolina
– -$53K -1,396 Closed
Bank of Montreal
135
Bank of Montreal
Ontario, Canada
– -$46K -1,226 Closed
PCM
136
Penserra Capital Management
California
– -$37K -990 Closed
SWM
137
Spire Wealth Management
Virginia
– -$8K -200 Closed
OSAM
138
O'Shaughnessy Asset Management
Connecticut
– -$5K -140 Closed
AssetMark Inc
139
AssetMark Inc
California
– -$5K -123 Closed
US Bancorp
140
US Bancorp
Minnesota
– -$4K -114 Closed
MLFP
141
MPS Loria Financial Planners
Illinois
– -$3K -100 Closed
Daiwa Securities Group
142
Daiwa Securities Group
Japan
– -$3K -87 Closed
CCA
143
Column Capital Advisors
Indiana
– -$2K -50 Closed
HI
144
Harbour Investments
Wisconsin
– -$2K -50 Closed
TWA
145
TCI Wealth Advisors
Arizona
– -$2K -50 Closed
SOW
146
State of Wyoming
Wyoming
– -$1K -26 Closed
2 3 4 5
6

FPRX Hedge Fund Activity: Q2 2021 in Review

0 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q2 2021, worth a combined $0 — down 100% from $1.56B a quarter earlier.

Sellers outnumbered buyers: 147 funds closed out of FPRX and 0 opened new positions — a net loss of 147 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BVF Inc, exiting entirely with an estimated $239M sold.

  • 0 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q2 2021, down from 147 in Q1 2021.
  • Funds reported $0 of Five Prime Therapeutics, Inc. stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Five Prime Therapeutics, Inc. positions in Q2 2021 and 147 closed out, a net change of -147 holders.
  • The largest Five Prime Therapeutics, Inc. seller in Q2 2021 was BVF Inc, an estimated $239M sold.

Based on aggregated 13F filings for Q2 2021.